Cargando…
The Midregional Fragment of Pro-A–Type Natriuretic Peptide, Blood Pressure, and Mortality in a Prospective Cohort Study of Patients With Type 2 Diabetes (ZODIAC-25)
OBJECTIVE: Evidence that midregional fragment of pro-A–type natriuretic peptide (MR-proANP) is a marker of mortality in patients with type 2 diabetes is limited. Therefore, we aimed to investigate the capabilities of MR-proANP in predicting mortality. We also investigated whether MR-proANP influence...
Autores principales: | van Hateren, Kornelis J.J., Landman, Gijs W.D., Kleefstra, Nanne, Groenier, Klaas H., Struck, Joachim, Navis, Gerjan J., Bakker, Stephan J.L., Houweling, Sebastiaan T., van der Meer, Klaas, Bilo, Henk J.G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631859/ https://www.ncbi.nlm.nih.gov/pubmed/23230100 http://dx.doi.org/10.2337/dc12-0428 |
Ejemplares similares
-
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16
por: Landman, Gijs W.D., et al.
Publicado: (2010) -
Health-Related Quality of Life and Mortality in a General and Elderly Population of Patients With Type 2 Diabetes (ZODIAC-18)
por: Landman, Gijs W.D., et al.
Publicado: (2010) -
A prospective observational study of quality of diabetes care in a shared care setting: trends and age differences (ZODIAC-19)
por: van Hateren, Kornelis J J, et al.
Publicado: (2012) -
The Lipid Profile and Mortality Risk in Elderly Type 2 Diabetic Patients: A Ten-Year Follow-Up Study (ZODIAC-13)
por: van Hateren, Kornelis J. J., et al.
Publicado: (2009) -
Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol
por: Schrijnders, Dennis, et al.
Publicado: (2017)